我国成人慢性肾脏病患者运动康复的专家共识

2019-07-30 中国医师协会康复医师分会 中华肾脏病杂志.2019,35(7):537-543.

慢性肾脏病(chronic kidney disease,CKD)患者随着肾功能下降,将会出现不同程度的心肺功能的下降、肌肉萎缩、生理、心理功能障碍,严重影响患者的生活质量(quality of life,QOL)。运动康复增加CKD 患者的心肺耐力、改善肌力和肌肉容积、降低心血管疾病风险、延缓CKD进展、提高QOL评分。适合CKD患者的运动康复处方,包括有氧运动、抗阻运动和灵活性运动,中等强度,

中文标题:

我国成人慢性肾脏病患者运动康复的专家共识

发布日期:

2019-07-30

简要介绍:

慢性肾脏病(chronic kidney disease,CKD)患者随着肾功能下降,将会出现不同程度的心肺功能的下降、肌肉萎缩、生理、心理功能障碍,严重影响患者的生活质量(quality of life,QOL)。运动康复增加CKD 患者的心肺耐力、改善肌力和肌肉容积、降低心血管疾病风险、延缓CKD进展、提高QOL评分。适合CKD患者的运动康复处方,包括有氧运动、抗阻运动和灵活性运动,中等强度,每次30~60 min,3~5次/周。对CKD患者做好运动康复前的评估,制定个体化运动处方,对降低运动相关不良事件的风险尤为重要。

 

拓展指南:慢性肾脏病相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=我国成人慢性肾脏病患者运动康复的专家共识)] GetToolGuiderByIdResponse(projectId=1, id=d7ebb1c001e83a62, title=我国成人慢性肾脏病患者运动康复的专家共识, enTitle=, guiderFrom=中华肾脏病杂志.2019,35(7):537-543., authorId=null, author=, summary=慢性肾脏病(chronic kidney disease,CKD)患者随着肾功能下降,将会出现不同程度的心肺功能的下降、肌肉萎缩、生理、心理功能障碍,严重影响患者的生活质量(quality of life,QOL)。运动康复增加CKD 患者的心肺耐力、改善肌力和肌肉容积、降低心血管疾病风险、延缓CKD进展、提高QOL评分。适合CKD患者的运动康复处方,包括有氧运动、抗阻运动和灵活性运动,中等强度,, cover=, journalId=null, articlesId=null, associationId=1180, associationName=中国医师协会康复医师分会, associationIntro=null, copyright=0, guiderPublishedTime=Tue Jul 30 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>慢性肾脏病(chronic kidney disease,CKD)患者随着肾功能下降,将会出现不同程度的心肺功能的下降、肌肉萎缩、生理、心理功能障碍,严重影响患者的生活质量(quality of life,QOL)。运动康复增加CKD 患者的心肺耐力、改善肌力和肌肉容积、降低心血管疾病风险、延缓CKD进展、提高QOL评分。适合CKD患者的运动康复处方,包括有氧运动、抗阻运动和灵活性运动,中等强度,每次30~60 min,3~5次/周。对CKD患者做好运动康复前的评估,制定个体化运动处方,对降低运动相关不良事件的风险尤为重要。 </P> <P> </P>拓展指南:<strong>与<font color=red>慢性肾脏病</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=509811c001e68a51" title="2型糖尿病合并慢性肾脏病患者口服降糖药治疗中国专家共识(2019年更新版)" target=_blank>2型糖尿病合并慢性肾脏病患者口服降糖药治疗中国专家共识(2019年更新版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=838161c001e58995" title="2019 BC指南:成人慢性肾脏病的识别,评估和管理(草案)" target=_blank>2019 BC指南:成人慢性肾脏病的识别,评估和管理(草案)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=753831c001e5696d" title="慢性肾脏病合并丙型肝炎病毒感染诊断及治疗的专家共识" target=_blank>慢性肾脏病合并丙型肝炎病毒感染诊断及治疗的专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=795741c001ea64bd" title="肾康制剂(肾康注射液、肾康栓)治疗慢性肾脏病合理应用专家共识" target=_blank>肾康制剂(肾康注射液、肾康栓)治疗慢性肾脏病合理应用专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=8880f1c0016e50b0" title="拟钙剂在慢性肾脏病患者中应用的专家共识" target=_blank>拟钙剂在慢性肾脏病患者中应用的专家共识</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E6%85%A2%E6%80%A7%E8%82%BE%E8%84%8F%E7%97%85" target=_blank>有关慢性肾脏病更多指南</a></ul>, tagList=[TagDto(tagId=2527, tagName=慢性肾脏病), TagDto(tagId=7787, tagName=运动康复)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=95, categoryName=康复医学, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12878, appHits=484, showAppHits=30, pcHits=4982, showPcHits=9015, likes=65, shares=29, comments=8, approvalStatus=1, publishedTime=Thu Aug 22 22:00:33 CST 2019, publishedTimeString=2019-07-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Aug 22 22:00:33 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 01:13:55 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=我国成人慢性肾脏病患者运动康复的专家共识)])
我国成人慢性肾脏病患者运动康复的专家共识
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1217018, encodeId=d894121e01848, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e215463835, createdName=ms8000001686551684, createdTime=Thu May 05 11:19:46 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978427, encodeId=0dac9e842757, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/3b5130b2a30842cb9ce5e18e81e36022/5fff01ba08fa45cbbf6da75dc530a822.jpg, createdBy=a2231751755, createdName=ms9700113925803558, createdTime=Thu Jul 01 00:05:52 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974272, encodeId=68a99e427220, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34f55526314, createdName=吖周, createdTime=Thu Jun 17 07:28:54 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974268, encodeId=deb29e426862, content=来学习的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34f55526314, createdName=ms6000001439002099, createdTime=Thu Jun 17 07:07:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968368, encodeId=d001968368ee, content=赚积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47bd5494652, createdName=ms4000001002527723, createdTime=Tue May 25 14:34:23 CST 2021, time=2021-05-25, status=1, ipAttribution=)]
    2022-05-05 ms8000001686551684

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1217018, encodeId=d894121e01848, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e215463835, createdName=ms8000001686551684, createdTime=Thu May 05 11:19:46 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978427, encodeId=0dac9e842757, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/3b5130b2a30842cb9ce5e18e81e36022/5fff01ba08fa45cbbf6da75dc530a822.jpg, createdBy=a2231751755, createdName=ms9700113925803558, createdTime=Thu Jul 01 00:05:52 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974272, encodeId=68a99e427220, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34f55526314, createdName=吖周, createdTime=Thu Jun 17 07:28:54 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974268, encodeId=deb29e426862, content=来学习的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34f55526314, createdName=ms6000001439002099, createdTime=Thu Jun 17 07:07:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968368, encodeId=d001968368ee, content=赚积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47bd5494652, createdName=ms4000001002527723, createdTime=Tue May 25 14:34:23 CST 2021, time=2021-05-25, status=1, ipAttribution=)]
    2021-07-01 ms9700113925803558

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1217018, encodeId=d894121e01848, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e215463835, createdName=ms8000001686551684, createdTime=Thu May 05 11:19:46 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978427, encodeId=0dac9e842757, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/3b5130b2a30842cb9ce5e18e81e36022/5fff01ba08fa45cbbf6da75dc530a822.jpg, createdBy=a2231751755, createdName=ms9700113925803558, createdTime=Thu Jul 01 00:05:52 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974272, encodeId=68a99e427220, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34f55526314, createdName=吖周, createdTime=Thu Jun 17 07:28:54 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974268, encodeId=deb29e426862, content=来学习的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34f55526314, createdName=ms6000001439002099, createdTime=Thu Jun 17 07:07:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968368, encodeId=d001968368ee, content=赚积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47bd5494652, createdName=ms4000001002527723, createdTime=Tue May 25 14:34:23 CST 2021, time=2021-05-25, status=1, ipAttribution=)]
    2021-06-17 吖周

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1217018, encodeId=d894121e01848, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e215463835, createdName=ms8000001686551684, createdTime=Thu May 05 11:19:46 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978427, encodeId=0dac9e842757, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/3b5130b2a30842cb9ce5e18e81e36022/5fff01ba08fa45cbbf6da75dc530a822.jpg, createdBy=a2231751755, createdName=ms9700113925803558, createdTime=Thu Jul 01 00:05:52 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974272, encodeId=68a99e427220, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34f55526314, createdName=吖周, createdTime=Thu Jun 17 07:28:54 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974268, encodeId=deb29e426862, content=来学习的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34f55526314, createdName=ms6000001439002099, createdTime=Thu Jun 17 07:07:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968368, encodeId=d001968368ee, content=赚积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47bd5494652, createdName=ms4000001002527723, createdTime=Tue May 25 14:34:23 CST 2021, time=2021-05-25, status=1, ipAttribution=)]
    2021-06-17 ms6000001439002099

    来学习的

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1217018, encodeId=d894121e01848, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e215463835, createdName=ms8000001686551684, createdTime=Thu May 05 11:19:46 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978427, encodeId=0dac9e842757, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/3b5130b2a30842cb9ce5e18e81e36022/5fff01ba08fa45cbbf6da75dc530a822.jpg, createdBy=a2231751755, createdName=ms9700113925803558, createdTime=Thu Jul 01 00:05:52 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974272, encodeId=68a99e427220, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34f55526314, createdName=吖周, createdTime=Thu Jun 17 07:28:54 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974268, encodeId=deb29e426862, content=来学习的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34f55526314, createdName=ms6000001439002099, createdTime=Thu Jun 17 07:07:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968368, encodeId=d001968368ee, content=赚积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47bd5494652, createdName=ms4000001002527723, createdTime=Tue May 25 14:34:23 CST 2021, time=2021-05-25, status=1, ipAttribution=)]
    2021-05-25 ms4000001002527723

    赚积分

    0